OR
Cardiology - Electrophysiology
This educational video explores contemporary antithrombotic management in patients with atrial fibrillation undergoing PCI. Using evidence from AUGUSTUS and current ACC/AHA guidelines, it examines the role of apixaban, the bleeding impact of aspirin, and the rationale for early de-escalation from triple therapy to oral anticoagulant plus P2Y12 inhibitor therapy. The video also highlights how ischemic and bleeding risks should guide treatment duration, particularly in patients with complex PCI or high stent-thrombosis risk.
0 Likes
0 Comments
Every decision in antithrombotic therapy carries a delicate balance between preventing thrombosis and minimizing bleeding risk. Join Clot Chronicles, a dedicated forum where healthcare professionals can engage in scientific discussions, gain practical clinical insights, and strengthen evidence-based decision-making to improve patient outcomes.
© 2026 i-rhythm, All Rights Reserved. MSN i-Rhythm does not provide medical advice, diagnosis or treatment.
For unrestricted access to content and a seamless experience,
Complete your profile to help us deliver a more personalized experience.